Forex News
ImageneBio grants inducement awards to three hires
ImageneBio granted inducement awards on Sept. 30, 2026, including 90,775 RSUs and 32,725 NSOs, to three newly hired non-executive employees.
- Awards were granted under Nasdaq Listing Rule 5635(c)(4).
- The package included 90,775 restricted stock units and 32,725 non-qualified stock options.
- Each NSO carries an exercise price of $4.58 per share.
Awards
ImageneBio said its Compensation Committee granted the inducement awards on Sept. 30, 2026. The package was given to three newly hired non-executive employees.
The awards consisted of 90,775 restricted stock units and 32,725 non-qualified stock options. Imagene said the grants were inducements material to the employees joining the company under Nasdaq Listing Rule 5635(c)(4).
Vesting
Two employees’ RSUs vest in equal annual installments over four years. The RSUs for the third employee vest over four years, with 25% vesting after one year and the rest in 12 equal quarterly installments.
Each NSO has an exercise price of $4.58 a share, equal to Imagene’s closing stock price on Sept. 30, 2026. The NSOs vest over four years, with 25% vesting after one year and the remaining 75% in equal monthly installments over the following 36 months.
Company
Imagene describes itself as a clinical-stage biotechnology company developing therapeutics for immunological, autoimmune and inflammatory diseases. It said its olevaprubart program has completed Phase 1b/2a trials in atopic dermatitis and alopecia areata, and is in a Phase 2b trial in moderate-to-severe atopic dermatitis.
Source: GlobeNewswire,